Amgen said on Monday its experimental therapy helped patients with advanced gastric cancer live longer when combined with ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Scientists from UCSD’s Sanford Stem Cell Institute are working in collaboration with Axiom Space and the JM Foundation on the ...

The FDA said risks linked to CAR-T cell therapies can be effectively communicated through existing labeling, including boxed ...

Despite recent ASCO and FDA guidance recommending the inclusion of people living with HIV in pivotal cancer trials, nearly 75 ...

After several years of development, Processa Pharmaceuticals has determined that the nearest milestone for anticancer asset ...

A potential treatment for glioblastoma crafted by scientists at The Wertheim UF Scripps Institute renders the deadly brain ...

Recent FDA decisions added new options for dermatologists involved in treating patients with psoriasis, bullous pemphigoid and advanced skin cancer. This FDA recap highlights recent approvals in April ...

Pfizer insists that the discontinuation of the Phase II study was due to recruitment difficulties and was not linked to ...

UnitedHealthcare and Memorial Sloan Kettering have been locked in a contract dispute that wasn’t resolved by the overnight ...